Comments
Jubilant Life Sciences has raised Rs 100 crore through issuance of commercial papers.
The company had issued commercial papers worth Rs 100 crore on April 18, 2017. The tenure of the instrument is 63 days, Jubilant Life Sciences said in a BSE filing today.
The company however did not specify what it planned to do with the money raised.
“The coupon/interest offered is 6.49 per cent per annum,” it added.
Commercial paper (CP) is an unsecured money market instrument issued in the form of a promissory note.
It was introduced in 1990 in India with a view to enable highly rated corporate borrowers to diversify their sources of short-term borrowings and to provide an additional instrument for investors.
Shares of Jubilant Life Sciences were trading 0.40 per cent higher at Rs 830.10 per scrip on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.